ChitogenX Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHNXF research report →
About the company
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development.
- CEO
- Pierre Laurin
- IPO
- 2020
- Employees
- 5
- HQ
- Kirkland, QC, CA
Price Chart
- Market Cap
- $627.63K
- P/E
- -0.23
- P/S
- 0.00
- P/B
- -0.06
- EV/EBITDA
- -6.35
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 19.40%
- ROIC
- 127.91%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,554,000 · 75.06%
- EPS
- $-0.02 · 83.62%
- Op Income
- $-2,830,000
- FCF YoY
- 68.44%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -2.06
- Avg Volume
- 29.29K
Get TickerSpark's AI analysis on CHNXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CHNXF coverage
Recent articles, reports, and earnings notes.
No research on CHNXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHNXF report →Similar companies
Peers in the same neighborhood.